{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:43:19Z","timestamp":1793763799508,"version":"4.6.1"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007055","name":"Third Military Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a progressive degenerative neurological illness with insidious onset. Due to the complexity of the pathogenesis of AD and different pathological changes, the clinical phenotypes of dementia are diverse, and these pathological changes also interact with each other. Therefore, it is of great significance to search for biomarkers that can diagnose these pathological changes to improve the ability to monitor the course of disease and treat the disease. The pathological mechanism hypothesis with high recognition of AD mainly includes the accumulation of \u03b2-amyloid (A\u03b2) around neurons and hyperphosphorylation of tau protein, which results in the development of neuronal fiber tangles (NFTs) and mitochondrial dysfunction. AD is an irreversible disease; currently, there is no clinical cure or delay in the disease process of drugs, and there is a lack of effective early clinical diagnosis methods. AD patients, often in the dementia stages and moderate cognitive impairment, will seek medical treatment. Biomarkers can help diagnose the presence or absence of specific diseases and their pathological processes, so early screening and diagnosis are crucial for the prevention and therapy of AD in clinical practice. \u03b2-amyloid deposition (A), tau pathology (T), and neurodegeneration\/neuronal damage (N), also known as the AT (N) biomarkers system, are widely validated core humoral markers for the diagnosis of AD. In this paper, the pathogenesis of AD related to AT (N) and the current research status of cerebrospinal fluid (CSF) and blood related biomarkers were reviewed. At the same time, the limitations of humoral markers in the diagnosis of AD were also discussed, and the future development of humoral markers for AD was prospected. In addition, the contents related to mitochondrial dysfunction, prion virology and intestinal microbiome related to AD are also described, so as to understand the pathogenesis of AD in many aspects and dimensions, so as to evaluate the pathological changes related to AD more comprehensively and accurately.<\/jats:p>","DOI":"10.3389\/fncel.2023.1279046","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T10:57:22Z","timestamp":1701946642000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Biomarkers associated with the pathogenesis of Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/mds.28779","article-title":"Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease.","volume":"36","author":"Aamodt","year":"2021","journal-title":"Mov. Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2174\/1389557520666200103100521","article-title":"Potent acetylcholinesterase inhibitors: potential drugs for Alzheimer\u2019s disease.","volume":"20","author":"Ak\u0131nc\u0131o\u011flu","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1012076","article-title":"Can probiotics mitigate age-related neuroinflammation leading to improved cognitive outcomes?","volume":"9","author":"Anderson","year":"2022","journal-title":"Front. Nutr."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043754","article-title":"Alzheimer\u2019s disease: An updated overview of its genetics.","volume":"24","author":"Andrade-Guerrero","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat8462","article-title":"A\u03b2 and tau prion-like activities decline with longevity in the Alzheimer\u2019s disease human brain.","volume":"11","author":"Aoyagi","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","article-title":"The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis.","volume":"19","author":"Ashleigh","year":"2023","journal-title":"Alzheimers Dement."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12431","article-title":"Chronic GCPII (glutamate-carboxypeptidase-II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques.","volume":"9","author":"Bathla","year":"2023","journal-title":"Alzheimers Dement."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.635104","article-title":"Exosomes: Innocent bystanders or critical culprits in neurodegenerative diseases.","volume":"9","author":"Beatriz","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: New hope for Alzheimer\u2019s disease therapeutics.","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J. Adv. Res."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice.","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s43587-021-00077-9","article-title":"The phosphorylation cascade hypothesis of Alzheimer\u2019s disease.","volume":"1","author":"Brinkmalm","year":"2021","journal-title":"Nat. Aging"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00163","article-title":"The association of tau with mitochondrial dysfunction in Alzheimer\u2019s disease.","volume":"12","author":"Cheng","year":"2018","journal-title":"Front. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1021\/acschemneuro.8b00457","article-title":"Pathological changes of tau related to Alzheimer\u2019s disease.","volume":"10","author":"Chu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-021-00805-8","article-title":"Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer\u2019s disease pathology and clinical disease progression.","volume":"13","author":"Clark","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/s1474-4422(20)30274-x","article-title":"Prion biology: implications for Alzheimer\u2019s disease therapeutics.","volume":"19","author":"Condello","year":"2020","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/genes13091564","article-title":"Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer\u2019s Disease.","volume":"13","author":"D\u2019Argenio","year":"2022","journal-title":"Genes"},{"key":"B17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neurol.2022.09.003","article-title":"Overview of the blood biomarkers in Alzheimer\u2019s disease: Promises and challenges.","volume":"179","author":"Delaby","year":"2023","journal-title":"Rev. Neurol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102386","article-title":"Tau promotes oxidative stress-associated cycling neurons in S phase as a pro-survival mechanism: Possible implication for Alzheimer\u2019s disease.","volume":"223","author":"Denechaud","year":"2023","journal-title":"Prog. Neurobiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12035-021-02612-6","article-title":"Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer\u2019s Disease.","volume":"59","author":"Dhapola","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jalz.2017.12.002","article-title":"Alzheimer\u2019s disease, cellular prion protein, and dolphins.","volume":"14","author":"Di Guardo","year":"2018","journal-title":"Alzheimer. Dement."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/s00415-022-11480-6","article-title":"Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders.","volume":"270","author":"Dinoto","year":"2023","journal-title":"J. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1580","DOI":"10.1212\/wnl.0000000000009240","article-title":"Total A\u03b242\/A\u03b240ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis.","volume":"94","author":"Doecke","year":"2020","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1178","article-title":"Microglia rely on SYK signalling to mount neuroprotective responses in models of Alzheimer\u2019s disease and multiple sclerosis.","volume":"2023","author":"Ennerfelt","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS.","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease.","volume":"22","author":"Fang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/biom12111676","article-title":"Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer\u2019s Disease and Identifying Promising Drug Targets.","volume":"12","author":"Fi\u0161ar","year":"2022","journal-title":"Biomolecules"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/alz.12581","article-title":"Trans-seeding of Alzheimer-related tau protein by a yeast prion.","volume":"18","author":"Flach","year":"2022","journal-title":"Alzheimer. Dement."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/alz.12508","article-title":"Plasma p-tau(181) shows stronger network association to Alzheimer\u2019s disease dementia than neurofilament light and total tau.","volume":"18","author":"Frank","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in Subjective Cognitive Decline and Mild Cognitive Impairment.","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1021\/acschemneuro.1c00209","article-title":"OAB-14 effectively ameliorates the dysfunction of the endosomal-autophagic-lysosomal pathway in APP\/PS1 transgenic mice.","volume":"12","author":"Guo","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jalz.2018.05.008","article-title":"The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer\u2019s disease diagnosis: A review.","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2022.212770","article-title":"Bioengineered microglia-targeted exosomes facilitate A\u03b2 clearance via enhancing activity of microglial lysosome for promoting cognitive recovery in Alzheimer\u2019s disease.","volume":"136","author":"Hao","year":"2022","journal-title":"Biomater. Adv."},{"key":"B34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tibs.2008.01.004","article-title":"A new take on prions: preventing Alzheimer\u2019s disease.","volume":"33","author":"Hooper","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/mp.2017.246","article-title":"Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review.","volume":"23","author":"Hopperton","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12264-022-00836-7","article-title":"Biofluid Biomarkers of Alzheimer\u2019s Disease: Progress, Problems, and Perspectives.","volume":"38","author":"Huang","year":"2022","journal-title":"Neurosci. Bull."},{"key":"B37","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1126\/science.aah6205","article-title":"Site-specific phosphorylation of tau inhibits amyloid-\u03b2 toxicity in Alzheimer\u2019s mice.","volume":"354","author":"Ittner","year":"2016","journal-title":"Science"},{"key":"B38","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1212\/WNL.0000000000207630","article-title":"Biomarkers in Alzheimer Disease.","volume":"101","author":"Karceski","year":"2023","journal-title":"Neurology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118165","article-title":"CRISPR\/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases.","volume":"59","author":"Karimian","year":"2020","journal-title":"Life Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and Abeta: implications for Alzheimer\u2019s disease pathology and therapeutics.","volume":"140","author":"Kent","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer\u2019s Disease: Cellular and Molecular Mechanisms.","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2017.06.1431","article-title":"Tau plasma levels in subjective cognitive decline results from the DELCODE study.","volume":"7","author":"Laske","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"B43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00018-017-2664-0","article-title":"Amyloid precursor protein products concentrate in a subset of exosomes specifically endocytosed by neurons.","volume":"75","author":"Laulagnier","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge.","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01127-4","article-title":"Alzheimer\u2019s disease brain contains tau fractions with differential prion-like activities.","volume":"9","author":"Li","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.937289","article-title":"Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases.","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3389\/fnins.2023.1242254","article-title":"Decoding the role of gut microbiota in Alzheimer\u2019s pathogenesis and envisioning future therapeutic avenues.","volume":"17","author":"Liang","year":"2023","journal-title":"Front. Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1007\/s12035-020-02073-3","article-title":"Gut Microbiota and Dysbiosis in Alzheimer\u2019s Disease: Implications for Pathogenesis and Treatment.","volume":"57","author":"Liu","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jalz.2019.01.015","article-title":"Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer\u2019s disease continuum in the BIOMARKAPD study.","volume":"15","author":"Lleo","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.4103\/1673-5374.274329","article-title":"Toxic tau: structural origins of tau aggregation in Alzheimer\u2019s disease.","volume":"15","author":"Mamun","year":"2020","journal-title":"Neural Regen. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1089\/ars.2007.1761","article-title":"Mitochondrial Cascade Hypothesis of Alzheimer\u2019s Disease: Myth or Reality?","volume":"9","author":"Mancuso","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11020215","article-title":"Cerebrospinal Fluid Biomarkers of Alzheimer\u2019s Disease: Current Evidence and Future Perspectives.","volume":"11","author":"McGrowder","year":"2021","journal-title":"Brain Sci."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.612757","article-title":"Hemachandra Reddy. Defective Autophagy and Mitophagy in Aging and Alzheimer\u2019s Disease.","volume":"14","author":"Michael Tran","year":"2021","journal-title":"Front. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1074\/jbc.M112.410944.57","article-title":"Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1.","volume":"288","author":"Morel","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08779-0","article-title":"Tau plasma levels in subjective cognitive decline: Results from the DELCODE study.","volume":"7","author":"M\u00fcller","year":"2017","journal-title":"Sci. Rep."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4759963","article-title":"Mechanisms of Mitochondrial Malfunction in Alzheimer\u2019s Disease: New Therapeutic Hope.","volume":"28","author":"Nabi","year":"2022","journal-title":"Oxid. Med. Cell. Long."},{"key":"B57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","article-title":"The complexity of tau in Alzheimer\u2019s disease.","volume":"705","author":"Naseri","year":"2019","journal-title":"Neurosci. Lett."},{"key":"B58","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s13402-017-0335-7","article-title":"MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR\/HIF-1alpha\/VEGF signaling axis in breast cancer cells.","volume":"40","author":"Pakravan","year":"2017","journal-title":"Cell Oncol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1123-7","article-title":"APP promotes osteoblast survival and bone formation by regulating mitochondrial function and preventing oxidative stress.","volume":"9","author":"Pan","year":"2018","journal-title":"Cell Death Dis."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010169","article-title":"Diagnostic Blood Biomarkers in Alzheimer\u2019s Disease.","volume":"10","author":"Park","year":"2022","journal-title":"Biomedicines"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13910","article-title":"Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer\u2019s disease.","volume":"53","author":"Pena-Bautista","year":"2023","journal-title":"Eur. J. Clin. Invest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.clinthera.2015.04.002","article-title":"Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.","volume":"37","author":"Petra","year":"2015","journal-title":"Clin. Therap."},{"key":"B63","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer\u2019s disease amyloid-beta peptides.","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","article-title":"Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes.","volume":"103","author":"Rajendran","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166759","article-title":"Rlip overexpression reduces oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease: Mechanistic insights.","volume":"1869","author":"Reddy","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd010803.pub2","article-title":"CSF tau and the CSF tau\/ABeta ratio for the diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI).","volume":"3","author":"Ritchie","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2017.08.007","article-title":"APP\/Abeta structural diversity and Alzheimer\u2019s disease pathogenesis.","volume":"110","author":"Roher","year":"2017","journal-title":"Neurochem. Int."},{"key":"B68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-neuro-070815-014015","article-title":"Alzheimer\u2019s Disease Mechanisms and Emerging Roads to Novel Therapeutics.","volume":"39","author":"Sala Frigerio","year":"2016","journal-title":"Annu. Rev. Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2174\/1568026619666190128125912","article-title":"Target Enzyme in Alzheimer\u2019s Disease: Acetylcholinesterase Inhibitors.","volume":"19","author":"Saxena","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse.","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00422-x","article-title":"Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer\u2019s disease","volume":"16","author":"Shafiq","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease.","volume":"17","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910794","article-title":"Exosomes in Alzheimer\u2019s disease: from being pathological players to potential diagnostics and therapeutics.","volume":"22","author":"Soliman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1007\/s12035-020-02248-y","article-title":"Aging-dependent mitophagy dysfunction in Alzheimer\u2019s disease.","volume":"58","author":"Song","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043970","article-title":"Specific mutations near the amyloid precursor protein cleavage site increase \u03b3-secretase sensitivity and modulate amyloid-\u03b2 production.","volume":"24","author":"Suzuki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3233\/jad-221286","article-title":"The Alzheimer\u2019s Disease Mitochondrial Cascade Hypothesis: A Current Overview.","volume":"92","author":"Swerdlow","year":"2023","journal-title":"J. Alzheimer Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.3233\/jad-2010-100339","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis.","volume":"20","author":"Swerdlow","year":"2010","journal-title":"J. Alzheimer Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"\u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease.","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med. Hypoth."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/jad-170585","article-title":"Mitochondria and Mitochondrial Cascades in Alzheimer\u2019s Disease.","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J. Alzheimer Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cell.2017.07.004","article-title":"Alzheimer\u2019s-causing mutations shift A\u03b2 length by destabilizing \u03b3-secretase-A\u03b2n interactions","volume":"170","author":"Szaruga","year":"2017","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030454","article-title":"The Pursuit of the \u201cInside\u201d of the Amyloid Hypothesis-Is C99 a Promising Therapeutic Target for Alzheimer\u2019s Disease?","volume":"12","author":"Takasugi","year":"2023","journal-title":"Cells"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jalz.2019.09.075","article-title":"The path forward in Alzheimer\u2019s disease therapeutics: Reevaluating the amyloid cascade hypothesis.","volume":"16","author":"Tolar","year":"2020","journal-title":"Alzheimer Dement."},{"key":"B83","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00401-011-0861-8","article-title":"Factors affecting Abeta plasma levels and their utility as biomarkers in ADNI.","volume":"122","author":"Toledo","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cell.2021.12.041","article-title":"Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.","volume":"185","author":"Tracy","year":"2022","journal-title":"Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1471-4159.2005.03053.x","article-title":"Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer\u2019s disease.","volume":"93","author":"Wang","year":"2005","journal-title":"J. Neurochem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpsychires.2019.10.002","article-title":"Increased ileal bile acid binding protein and galectin-9 are associated with mild cognitive impairment and Alzheimer\u2019s disease.","volume":"119","author":"Wang","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00294","article-title":"Modifications and Trafficking of APP in the Pathogenesis of Alzheimer\u2019s Disease.","volume":"10","author":"Wang","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1212\/WNL.0000000000004667","article-title":"Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.","volume":"89","author":"Weston","year":"2017","journal-title":"Neurology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1042\/bst20220518","article-title":"Interactions between amyloid, amyloid precursor protein, and mitochondria.","volume":"51","author":"Wilkins","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases.","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.14336\/AD.2022.0412","article-title":"Amyloid Cascade Hypothesis for the Treatment of Alzheimer\u2019s Disease: Progress and Challenges.","volume":"13","author":"Wu","year":"2022","journal-title":"Aging Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s12264-022-00907-9","article-title":"Microglia-Mediated Abeta Propagation in Alzheimer\u2019s Disease.","volume":"38","author":"Yang","year":"2022","journal-title":"Neurosci. Bull."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27572-2.11","article-title":"Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer\u2019s disease.","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1007\/s12035-022-02817-3","article-title":"Serpin Signatures in Prion and Alzheimer\u2019s Diseases.","volume":"59","author":"Zattoni","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3233\/JAD-215456","article-title":"The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer\u2019s Disease Continuum: A Longitudinal Study.","volume":"85","author":"Zhang","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between Abeta and Tau in the Pathogenesis of Alzheimer\u2019s Disease.","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B97","article-title":"Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer\u2019s disease.","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"B98","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12035-014-8886-3","article-title":"Beta-Amyloid Precursor Protein (\u03b2APP) Processing in Alzheimer\u2019s Disease (AD) and Age-Related Macular Degeneration (AMD).","volume":"52","author":"Zhao","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn9380","article-title":"Synaptogenic effect of APP-Swedish mutation in familial Alzheimer\u2019s disease.","volume":"14","author":"Zhou","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.544235","article-title":"Target dysbiosis of gut microbes as a future therapeutic manipulation in Alzheimer\u2019s disease.","volume":"12","author":"Zhu","year":"2020","journal-title":"Front. Aging Neurosci."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2023.1279046\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T10:57:29Z","timestamp":1701946649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2023.1279046\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":100,"alternative-id":["10.3389\/fncel.2023.1279046"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2023.1279046","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"article-number":"1279046"}}